Institut Paoli-Calmettes Pancreatic Neoplasms Database

August 16, 2016 updated by: Institut Paoli-Calmettes
Database of Institut Paoli Calmettes diagnosed with Pancreatic neoplasms

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

8500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
    • Bouches du Rhone
      • Marseille, Bouches du Rhone, France, 13009
        • Recruiting
        • Institut Paoli Calmettes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with a diagnosis of Pancreatic neoplasms

Description

Inclusion Criteria:

  • Patient with a diagnosis of Pancreatic neoplasm

Exclusion Criteria:

  • Patient with a diagnosis of cholangiocarcinoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with diagnosis of Pancreatic neoplasms
Other: Data collection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival of patients with pancreatic neoplasms
Time Frame: 10 years
Overall survival of all patients who come in the center
10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collection of patients characteristics
Time Frame: 10 years
Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institut Paoli-Calmettes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2000

Primary Completion (Anticipated)

January 1, 2030

Study Completion (Anticipated)

December 1, 2030

Study Registration Dates

First Submitted

August 11, 2016

First Submitted That Met QC Criteria

August 16, 2016

First Posted (Estimate)

August 17, 2016

Study Record Updates

Last Update Posted (Estimate)

August 17, 2016

Last Update Submitted That Met QC Criteria

August 16, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BDD-PANCREAS-IPC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pancreatic Neoplasms

Clinical Trials on Data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe